Avelumab Becomes First Approved Treatment for Patients with Merkel Cell Carcinoma

The FDA has approved the first drug ever for the rare skin cancer, Merkel cell carcinoma, and updated data show an improved tumor response rate and that patients’ tumors continued to respond for at least a year.

Cancer Currents: An NCI Cancer Research Blog